Search Results
OS after progression on first novel hormonal therapy in mCSPC vs mCRPC
Survival outcomes and characterization of mCSPC
First-line treatments for patients with mHSPC and mCRPC
Comparative Data on First Line mCRPC From ASCO GU 2018
Genomic characterization of patients with de-novo high-volume mCSPC compared to those without
PROPHECY trial: AR-V7 CTCs as a biomarker in mCRPC
AUA2019 048IC: Novel Agents & Concepts in the Management of Hormone Naïve & CRPC
Changing the Treatment Story With Hormonal Therapy in Prostate Cancer
Novel Hormonal Therapies for Prostate Cancer
Results from ACIS Trial of Apalutamide + Abiraterone/Prednisone in Patients with Chemo-Naive mCRPC
ACIS Trial of Apalutamide and Abiraterone in Chemotherapy-Naïve mCRPC
Latest updates in the management of mHSPC patients by Edmund CHIONG
